30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Aurora Spine Sales Decline on Product Line Cannibalization -

Aurora Spine reported 3Q19 revenue of USD $2.5 million, -5.4% vs. 3Q18.


  • Aurora Spine has seen rapid acceleration of sales of third-party products over the last two quarters, but those sales have cannibalized Aurora products resulting in lower margins; for context, sales of Aurora products increased less than 1% for the nine-month period ending September 30, 2019 while sales of third-party products almost doubled
  • For the quarter, the company saw increases sales of cervical screws, plates and biologics offset by a decrease in cervical and lumbar cages as well as ZIP products
  • Exploring options including vendors allowing Aurora branding on licensed products, pricing adjustments on third-party products and acquiring FDA-cleared products to fill portfolio gaps
  • Expects to launch an SI joint fusion product in 1Q20 and the ZIPFlex motion-preservation implant late in 2020
  • ORTHOWORLD projects Aurora Spine full year 2019 revenue of $11.1 million, +27.4% vs. 2018


ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM).

  3Q19 3Q18 $ Chg % Chg
Spine $2.4 $2.5 -$0.1 -5.9%
Orthobiologics $0.2 $0.2 $0.0 2.4%
Total $2.5 $2.7 -$0.1 -5.4%
  9Mo 19 9Mo 18 $ Chg % Chg
Spine $8.0 $5.8 $2.2 38.1%
Orthobiologics $0.5 $0.4 $0.1 33.2%
Total $8.5 $6.2 $2.3 37.8%


Mike Evers is ORTHOWORLD’s Digital Content Strategist. He can be reached by email.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.